2020
DOI: 10.1080/14656566.2020.1856814
|View full text |Cite
|
Sign up to set email alerts
|

Emerging and state of the art hemagglutinin-targeted influenza virus inhibitors.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(14 citation statements)
references
References 144 publications
0
14
0
Order By: Relevance
“…Therefore, additional studies are required to address the detailed mechanisms underlying the local production of IgT-specific responses in the SB mucosa. It is also worth noting that influenza hemagglutinin-specific IgA is produced locally in the mice lung tissue 58 60 .…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, additional studies are required to address the detailed mechanisms underlying the local production of IgT-specific responses in the SB mucosa. It is also worth noting that influenza hemagglutinin-specific IgA is produced locally in the mice lung tissue 58 60 .…”
Section: Discussionmentioning
confidence: 99%
“…Till now, a series of small protein or peptide viral fusion inhibitors targeting conserved epitopes of HA stem have been developed, such as HB36 and HB80 (19), HB36.3 and HB80.4 (23), HB36.6 (21), JNJ4796 (22), P7 (20). Some of these inhibitors have been shown to protect mice from influenza virus infection, such as HB36.6 and JNJ4796 (21,22), and four antibody drugs (CR6261, 39.29, CR8020 and MEDI8852) have entered phase II clinical trial (136)(137)(138). In addition, several universal vaccines based on the HA stem, such as headless HA and HA mini-stems, have also shown promising prospects, and chimeric HA has entered phase I clinical trial (136,137).…”
Section: Epitopes Of the Hydrophobic Groove Regionmentioning
confidence: 99%
“…The highly conserved HA stem, which produces protective antibodies that neutralize viral infectivity without inhibiting hemagglutination, is a more attractive target for the development of a universal influenza vaccine. Many studies have shown that this site contains many antigenic epitopes that bind broad-spectrum neutralizing antibodies (bnAbs) and has an important role in inhibiting viral entry into cells [ 34 , 35 , 36 , 37 ].…”
Section: Development Of Universal Influenza Vaccinementioning
confidence: 99%